Key result
CYP4A11 rs3890011 GG genotype is linked to higher risk of coronary artery disease.
Case-Control (n=676)
Answers are grounded in this paper and cite their sources.
BACKGROUND: CYP4A11 (cytochrome P450, family 4, subfamily A, polypeptide 11) converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which plays a crucial role in the modulation of cardiovascular homeostasis. The aim of the present study was to assess the association between the human CYP4A11 gene and coronary artery disease (CAD). METHODS: A total of 361 patients with CAD and 315 controls were genotyped for 4 single-nucleotide polymorphisms (SNPs) of the human CYP4A11 gene (rs9332978, rs4660980, rs3890011, and rs1126742). The data were assessed for 3 groups: total participants, men, and women via case-control studies. RESULTS: For total participants and men, the distribution of SNP3 (rs3890011) genotypes showed a significant difference between CAD and control participants (P = .030 and P = .013, respectively), the distribution of the recessive model of SNP3 (GG vs CC + GC) was significantly higher in CAD patients than in control participants (P = .011 and P = .014, respectively), the significant difference was retained after adjustment for covariates (for total participants, 95% confidence interval [CI]: 1.137-2.423, P = .009; and for males, 95% CI: 1.173-3.013, P = .009). CONCLUSIONS: rs3890011 maybe a novel polymorphism of the CYP4A11 gene associated with CAD in a Han Chinese population.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2012) conducted a case-control in Coronary artery disease (n=676). CYP4A11 gene polymorphism rs3890011 (GG genotype) vs. CC + GC genotypes (recessive model) was evaluated on Coronary artery disease (95% CI 1.137-2.423, p=0.009). The CYP4A11 rs3890011 polymorphism (recessive model GG vs CC+GC) was associated with coronary artery disease after covariate adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: